Literature DB >> 2302201

Androgen receptor heterogeneity and phosphorylation in human LNCaP cells.

J H van Laar1, J Bolt-de Vries, N D Zegers, J Trapman, A O Brinkmann.   

Abstract

Androgen receptor heterogeneity and phosphorylation were studied in the human LNCaP cell line. Fluorography after photoaffinity labeling as well as immunoblotting with a specific polyclonal antibody revealed that the human androgen receptor migrated as a closely spaced 110 kD doublet on SDS-polyacrylamide gels. A time-dependent change in the ratio between the two isoforms was not observed after R1881 treatment of intact cells. In nuclear extracts of LNCaP cells that were incubated with [32P]orthophosphate in the presence of 10 nM R1881, a 110 kD phosphorylated protein was demonstrated after immunopurification using a monoclonal antibody against the human androgen receptor. Only a very small amount of this phosphoprotein was detected in the nuclear fraction from cells not treated with R1881. These results indicate that the human androgen receptor in LNCaP cells can be phosphorylated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302201     DOI: 10.1016/0006-291x(90)91930-q

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor.

Authors:  G G Kuiper; P E de Ruiter; J Trapman; W J Boersma; J A Grootegoed; A O Brinkmann
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

3.  Androgen receptor serine 81 mediates Pin1 interaction and activity.

Authors:  Raffaele La Montagna; Isabella Caligiuri; Pasquale Maranta; Chiara Lucchetti; Luca Esposito; Marco G Paggi; Giuseppe Toffoli; Flavio Rizzolio; Antonio Giordano
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

4.  Kinase modulation of androgen receptor signaling: implications for prostate cancer.

Authors:  Kalpit Shah; Neil A Bradbury
Journal:  Cancer Cell Microenviron       Date:  2015-11-19

5.  Phosphorylation of androgen receptor isoforms.

Authors:  Hao Yun Wong; Jan A Burghoorn; Marije Van Leeuwen; Petra E De Ruiter; Esther Schippers; Leen J Blok; Ka Wan Li; Henk L Dekker; Luitzen De Jong; Jan Trapman; J Anton Grootegoed; Albert O Brinkmann
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

Review 6.  The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.

Authors:  Michael V Fiandalo; Wenjie Wu; James L Mohler
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

7.  Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle.

Authors:  K Inoue; S Yamasaki; T Fushiki; Y Okada; E Sugimoto
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

Review 8.  Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.

Authors:  Soha Salama El Sheikh; Jan Domin; Paul Abel; Gordon Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

9.  Proline-Directed Androgen Receptor Phosphorylation.

Authors:  Yanfei Gao; Shaoyong Chen
Journal:  J Mol Genet Med       Date:  2013-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.